1. Home
  2. RC vs VRXA Comparison

RC vs VRXA Comparison

Compare RC & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ready Capital Corproation

RC

Ready Capital Corproation

N/A

Current Price

$1.87

Market Cap

272.6M

Sector

Real Estate

ML Signal

N/A

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$1.78

Market Cap

263.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RC
VRXA
Founded
2007
N/A
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.6M
263.0M
IPO Year
2011
2025

Fundamental Metrics

Financial Performance
Metric
RC
VRXA
Price
$1.87
$1.78
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$2.81
N/A
AVG Volume (30 Days)
1.1M
141.8K
Earning Date
05-07-2026
N/A
Dividend Yield
2.16%
N/A
EPS Growth
45.25
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$67.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$1.70
52 Week High
$4.47
$4.50

Technical Indicators

Market Signals
Indicator
RC
VRXA
Relative Strength Index (RSI) 61.77 37.12
Support Level $1.52 $1.74
Resistance Level $2.17 $2.00
Average True Range (ATR) 0.11 0.13
MACD 0.02 0.04
Stochastic Oscillator 83.91 23.20

Price Performance

Historical Comparison
RC
VRXA

About RC Ready Capital Corproation

Ready Capital Corp is a real estate finance company that originates, acquires, finances, and services LMM loans, SBA loans, construction loans, USDA loans and, to a lesser extent, MBS collateralized mainly by LMM loans or other real estate-related investments. Its loans are used by businesses to purchase real estate used in their operations or by investors seeking to acquire multi-family, office, retail, mixed use or warehouse properties. It operates through two segments: LMM Commercial Real Estate, which originates LMM loans across the life-cycle of an LMM property including construction, bridge, stabilized and agency loan channels, and Small Business Lending, which acquires, originates and services owner-occupied loans guaranteed by the SBA and also originates and services USDA loans.

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: